UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 262

Sortiert nach

Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

Investigational new drugs, 2018-02, Vol.36 (1), p.96-102

2018

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs and cancer: past, present, and potential future

Molecular cancer therapeutics, 2008-12, Vol.7 (12), p.3655-3660

2008

Link zum Volltext

Verfügbarkeit prüfen

STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma

PloS one, 2012-02, Vol.7 (2), p.e30820-e30820

2012

Link zum Volltext

Verfügbarkeit prüfen

miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-03, Vol.6 (3), p.482-488

2011

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic

PloS one, 2014-07, Vol.9 (7), p.e100244-e100244

2014

Link zum Volltext

Verfügbarkeit prüfen

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Journal of the American Academy of Dermatology, 2014-01, Vol.70 (1), p.60-69

2014

Link zum Volltext

Verfügbarkeit prüfen

Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients

PloS one, 2021-11, Vol.16 (11), p.e0259898-e0259898

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictable modulation of cancer treatment outcomes by the gut microbiota

Microbiome, 2020-03, Vol.8 (1), p.28-28, Article 28

2020

Link zum Volltext

Verfügbarkeit prüfen

Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions

Nature communications, 2023-05, Vol.14 (1), p.2673-2673, Article 2673

2023

Link zum Volltext

Verfügbarkeit prüfen

BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity

PloS one, 2022-05, Vol.17 (5), p.e0266980-e0266980

2022

Link zum Volltext

Verfügbarkeit prüfen

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status

Oncoimmunology, 2023-12, Vol.12 (1), p.2204746-2204746

2023

Link zum Volltext

Verfügbarkeit prüfen

TMB or not TMB as a biomarker: That is the question

Critical reviews in oncology/hematology, 2021-07, Vol.163, p.103374-103374, Article 103374

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs

BMC genomics, 2013-05, Vol.14 (1), p.302-302, Article 302

2013

Link zum Volltext

Verfügbarkeit prüfen

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)

PloS one, 2016-01, Vol.11 (1), p.e0144797-e0144797

2016

Link zum Volltext

Verfügbarkeit prüfen

CRL4A-FBXW5–mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth

Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (42), p.16868-16873

2013

Link zum Volltext

Verfügbarkeit prüfen

Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer

Cancers, 2023-10, Vol.15 (20), p.5091

2023

Link zum Volltext

Verfügbarkeit prüfen

A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges

PloS one, 2013-10, Vol.8 (10), p.e76438-e76438

2013

Link zum Volltext

Verfügbarkeit prüfen

A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy

PloS one, 2017-11, Vol.12 (11), p.e0188628-e0188628

2017

Link zum Volltext

Verfügbarkeit prüfen

Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication

PeerJ (San Francisco, CA), 2019-02, Vol.7, p.e6423-e6423, Article e6423

2019

Link zum Volltext

Verfügbarkeit prüfen

Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)

Translational oncology, 2019-12, Vol.12 (12), p.1539-1548

2019

Link zum Volltext

Verfügbarkeit prüfen

KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures

Cancer treatment reviews, 2020-04, Vol.85, p.101978-101978, Article 101978

2020

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer

PeerJ (San Francisco, CA), 2019-07, Vol.7, p.e7232-e7232, Article e7232

2019

Link zum Volltext

Verfügbarkeit prüfen

A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy

PloS one, 2017-06, Vol.12 (6), p.e0179170-e0179170

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(146)
Life Sciences & Biomedicine
(123)
Humans
(119)
Oncology
(95)
Male
(73)
Female
(71)
Middle Aged
(56)
Adult
(54)
Aged
(54)
Tumors
(44)
Neoplasms - Drug Therapy
(34)
Aged, 80 And Over
(31)
Treatment Outcome
(30)
Biological And Medical Sciences
(28)
Cancer
(28)
Medical Sciences
(28)
Lung Cancer
(26)
Antineoplastic Agents - Therapeutic Use
(25)
Cancer Therapies
(24)
Patients
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

MicroRNAs and cancer: past, present, and potential future

STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma

miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic

Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients

Predictable modulation of cancer treatment outcomes by the gut microbiota

Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions

BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status

TMB or not TMB as a biomarker: That is the question

Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)

CRL4A-FBXW5–mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth

Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer

A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges

A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy

Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication

Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)

KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures

Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer

A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy

Suchergebnisse filtern